Nucleic acid encoding anti-IgE antibodies

Details Nucleic acid encoding anti-IgE antibodies Nucleic acid encoding anti-IgE antibodies

2008-04-01

2008-04-01

Rawlings, Stephen L. (Department: 1643)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C530S387100, C530S387300, C435S070100, C435S320100, C435S326000, C435S328000

Reexamination Certificate

active

07351816

ABSTRACT:
The present invention describes IgE antagonists (including variant anti-IgE antibodies) and their use in diagnosis, therapy or prophylaxis of allergic and other IgE-mediated disorders, including asthma, food allergies, hypersensitivity and anaphylactic reactions.

REFERENCES:
patent: 4629783 (1986-12-01), Cosand
patent: 4714759 (1987-12-01), Whitaker, Jr.
patent: 4861579 (1989-08-01), Meyer et al.
patent: 4940782 (1990-07-01), Rup et al.
patent: 5428133 (1995-06-01), Chang
patent: 5585089 (1996-12-01), Queen et al.
patent: 5821337 (1998-10-01), Carter et al.
patent: 6329509 (2001-12-01), Jardieu et al.
patent: 6685939 (2004-02-01), Jardieu et al.
patent: 6699472 (2004-03-01), Jardieu et al.
patent: 6914129 (2005-07-01), Jardieu et al.
patent: 255249 (1988-02-01), None
patent: 263655 (1988-04-01), None
patent: 58-156285 (1983-09-01), None
patent: WO 89/04834 (1989-06-01), None
patent: WO 89/06138 (1989-07-01), None
patent: WO 90/07861 (1990-07-01), None
patent: WO 91/09967 (1991-07-01), None
patent: WO 91/09968 (1991-07-01), None
Elgert et al., Immunology: Understanging the Immune System, 1996, p. 59.
Simmons et al., Journal of Immunogical Methods, 263:133-147, May 2002.
Jones, DT., Pharmacogenomics Jornal, 1:126-134, 2001.
Tosatto et al., Surrent Pharmaceutical Design, 12:2067-2086, 2006.
Mariuzza et al. (Annu. Rev. Biophys. Biophys. Chem. 1987; 16: 139-159).
Gussow et al. (Methods in Enzymology. 1991; 203: 99-121).
Hamilton (Clin. Chem. 40(11):2186-2192, 1994).
U.S. Appl. No. 08/146,206, filed Nov. 17, 1993, Carter et al.
Baniyash et al., “Anit-IgE monoclonal antibodies directed at the Fcεreceptor binding site”Molecular Immunology25(8):705-711 (1988).
Baniyash et al., “Inhibition of IgE Binding to Mast Cells and Basophils by Monoclonal Antibodies to Murine IgE”European Journal of Immunology14:799-807 (1984).
Baniyash, “Immunochemical Characterization of the Interaction Between Immunoglobulin E and Its Receptor”Weizmann Institute of Science(Thesis) (May 1986).
Burgess et al., “Possible Dissociation of the Heparin-binding and Mitogenic Activities of Heparin-binding (Acidic Fibroblast) Growth Factor-1 from Its Receptor-binding Activities by Site-directed Mutagenesis of a Single Lysine Residue” Journal of Cell Biology 111:2129-2138 (1990).
Burt et al., “Analysis of the interaction between rat immunoglobulin E and rat mast cells using anti-peptide antibodies”Molecular Immunology24(4):379-389 (1987).
Burt et al., “Inhibition of binding of rat IgE to rat mast cells by synthetic IgE peptides”European Journal of Immunology17:437-440 (1987).
Casale et al., “Recombinant Human Monoclonal Anti-IgE Therapy in Allergic Rhinitis”Journal Allergy Clinical Immunology(Abstract) 97(1):Part 3 (1996).
Conrad et al., “The Interation of Human and Rodent IgE with the Human Basophil IgE Receptor”J. of Immunology130(1): 327-333 (1983).
Conrad, D.H., “FcεRII/CD23: The low affinity receptor for IgE”Ann. Rev. Immunol. 8:623-639 (1990).
Deisenhofer, J, “Crystallographic Refinement and Atomic Models of a Human Fc Fragment and Its Complex with Fragment B of Protein A fromStaphylococcus aureusat 2.9- and 2.8-A Resolution”Biochemistry20(9):2361-2370 (1981).
Duncan et al., “Localization of the Binding Site for the Human High-Affinity Fc Receptor on IgG.”Nature332:563-564 (Apr. 7, 1988).
Emery et al., “Humanised monoclonal antibodies for therapeutic applications”Exp. Opin. Invest. Drugs3(3):241-251 (1994).
Geha et al., “IgE sites relevant for binding to type 1 Fc epsilon (FCER) receptors on mast cells”J. Allergy&Clin. Immunol.(Abstract No. 20) 79(1):129 (1987).
Gillies et al., “Antigen Binding and Biological Activities of Engineered Mutant Chimeric Antibodies with Human Tumor Specificities”Hum. Antibod. Hybridomas1(1):47-54 (1990).
Glennie et al., “Preparation and Performance of Bispecific F(ab'γ)2Antibody Containing Thioether-Linked Fab'γ Fragments”J. Immunol.139(7):2367-2375 (Oct. 1, 1987).
Hakimi et al., “The α subunit of the human Ige receptor (FcERI) is sufficient for high affinity IgE binding”Journal of Biological Chemistry265(36):22079-22081 (1990).
Helm et al., “Blocking of passive sensitization of human mast cells and basophil granulocytes with IgE antibodies by a reconbinant human ε-chain fragment of 76 amino acids”Proc. Natl. Acad. Sci.86:9465-9469 (Dec. 1989).
Helm et al., “Identification of the High Affinity Receptor Binding Region in Human Immunoglobulin E”Journal of Biological Chemistry271(13):7494-7500 (Mar. 29, 1996).
Helm et al., “The mast cell binding site on human immunoglobulin E”Nature331:180-183 (Jan. 14, 1988).
Hoffman, D. R., “Enzyme-linked immunosorbent assays (ELISA) for immunoglobulin E and blocking antibodies”Methods in Enzymology, Chapter 45, 73:656-666 (1981).
Hook et al., “Monoclonal Antibodies Defining Epitopes on Human IgE”Molecular Immunology28(6):631-639 (1991).
Ishizaka et al., “Mechanisms of passive sensitization III. Number of IgE Molecules and Their Receptor Sites on Human Basophil Granulocytes”J. Immunol.111(2) :500-511 (Aug. 1973).
Ishizaka, K., “Immunoglobulin E (IgE)”Methods in Enzymology116(Part II):76-94 (1985).
Jefferis et al., “Molecular Definition of Interaction Sites on Human IgG for Fc Receptors (huFcγR) ”Molecular Immunology27(12):1237-1240 (1990).
Jefferis, R., “Structure-function relationships in human immunoglobulins”Netherlands J. Medicine39:188-198 (1991).
Jones et al., “Replacing the Complementarity-Determining Regions in a Human Antibody with Those From a Mouse.”Nature. 321:522-525 (May 29, 1986).
KabatSequences of Proteins of Immunological Interest(Fourth Ed.), 4th edition pps. 41-42, 167-168 (1987).
Kahan, “Immunosuppressive therapy”Current Opinion in Immunology4(5):553-560 (Oct. 1992).
Kulczycki et al., “The Interaction of IgE with Rat Basophilic Leukemia Cells, Evidence for Specific Binding of IgE”Journal of Experimental Medicine139:600-616 (1974).
Kumar et al., “Amino acid variations at a single residue in an autoimmune peptide, etc.”P.N.A.S USA87:1337-1341 (Feb. 1990).
Kurokawa et al., “Expression of human immunoglobulin E ε chain cDNA inE. coli”Nucleic Acids Research11(10):3077-3085 (1983).
Lazar et al., “Transforming Growth Factor α: Mutation of Aspartic Acid 47 and Leucine 48 Results in Different Biological Activities”Molecular&Cellular Biology8(3):1247-1252 (Mar. 1988).
Liu et al., “Expression of a biologically active fragment of human IgE ε chain inEscherichia coli”Proc. Natl. Acad. Sci.81:5369-5373 (Sep. 1984).
Metzger and Kinet, “How Antibodies Work: Focus on Fc Receptors”FASEB J2(1):3-11 (Jan. 1988).
Neurath, A. R., “Use of125I-labeled anti-2, 4-dinitrophenyl (DNP) antibodies as a general tracer in solid-phase radioimmunoassays”Methods in Enzymology73:127-138 (1981).
Nio et al., “Inhibition of histamine release by synthetic human IgE peptide fragments: structure-activity studies”Peptide Chemistrypp. 203-208 (1989).
Nissim et al., “Fine specifically of the IgE Interaction with the Low and High Affinity Fc Receptor”J. Immunol.150:1365-1374 (1993).
Nissim et al., “Mapping of the high affinity Fcε receptor binding site to the third constant region domain of IgE”EMBO Journal10(1):101-107 (Jan. 1991).
Nissim et al., “The Use of Mouse/Human IgE Chimeras to Map the FceR Binding Site of IgE”Methods8:124-132 (1995).
Nitta et al., “Preliminary trial of specific targeting therapy against malignant glioma”Lancet335(8686):368-371 (Feb. 17, 1990).
Padlan et al., “A model of the Fc of immunoglobulin E”Molecular Immunology23(10):1063-

Affiliated with

Also associated with

Rating

Nucleic acid encoding anti-IgE antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid encoding anti-IgE antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid encoding anti-IgE antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2745902